Tennessee crypto ATM ban remains in force
A US federal court has allowed Tennessee's ban on cryptocurrency ATMs to remain in force after denying an emergency request by CoinFlip and Private IT Corporation to block the law.

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
A US federal court has allowed Tennessee's ban on cryptocurrency ATMs to remain in force after denying an emergency request by CoinFlip and Private IT Corporation to block the law.
Finder Energy (ASX:FDR) has secured formal approval from the Autoridade Nacional do Petróleo for its field development plan covering the Kuda Tasi and Jahal oilfields.
Circle faces a key regulatory deadline on July 18 as US agencies are required to publish implementation rules under the GENIUS Act governing stablecoin issuance, reserves, licensing and supervision.
Bank of England Governor Andrew Bailey said Nigel Farage did not influence the central bank's approach to a potential central bank digital currency after the two discussed cryptocurrencies during a meeting.
DPM Metals (ASX:DPM) reported preliminary second-quarter production results for 2026, delivering 102 Koz of gold equivalent ounces.
India's tax department found that fewer than a quarter of 645,000 people who traded cryptocurrency during the year ended March 2023 reported those transactions on their tax returns.
The IMF downgraded Australia's forecast economic growth for 2026 to 1.9% amid persistent inflationary pressures.
Chevron Technical Center, a division of Chevron U.S.A. (NYSE:CVX) and a subsidiary of Chevron Corporation, has finalized a technology licensing agreement allowing ZL Chemicals to commercialize its proprietary advanced chemical surfactant technology.
Prime Medicine (NASDAQ:PRME) secured a definitive binding arbitration victory against Beam Therapeutics regarding the clinical development rights for its Alpha-1 Antitrypsin Deficiency pipeline asset PM647.
The United States Food and Drug Administration accepted a New Drug Application from Immunome (NASDAQ:IMNM) for its oral tumor treatment varegacestat following clinical trial data showing an 84% reduction in disease progression risk.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy